The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Louis S. Matza

Center for Health Outcomes Research

United BioSource Corporation


MD 20814



Name/email consistency: high



  • Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA. 2005 - 2009
  • The MEDTAP Institute at UBC, Bethesda, Maryland 20814, USA. 2005


  1. Derivation and validation of the ASK-12 adherence barrier survey. Matza, L.S., Park, J., Coyne, K.S., Skinner, E.P., Malley, K.G., Wolever, R.Q. Ann. Pharmacother (2009) [Pubmed]
  2. Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population . Matza, L.S., Yu-Isenberg, K.S., Coyne, K.S., Park, J., Wakefield, J., Skinner, E.P., Wolever, R.Q. Curr. Med. Res. Opin (2008) [Pubmed]
  3. The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy. Matza, L.S., Rousculp, M.D., Malley, K., Boye, K.S., Oglesby, A. Health. Qual. Life. Outcomes (2008) [Pubmed]
  4. Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Matza, L.S., Johnston, J.A., Faries, D.E., Malley, K.G., Brod, M. Qual. Life. Res (2007) [Pubmed]
  5. Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change. Matza, L.S., Yurgin, N., Boye, K.S., Malley, K., Shorr, J.M. Curr. Med. Res. Opin (2007) [Pubmed]
  6. Utilities and disutilities for type 2 diabetes treatment-related attributes. Matza, L.S., Boye, K.S., Yurgin, N., Brewster-Jordan, J., Mannix, S., Shorr, J.M., Barber, B.L. Qual. Life. Res (2007) [Pubmed]
  7. Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Matza, L.S., Boye, K.S., Yurgin, N. Health. Qual. Life. Outcomes (2007) [Pubmed]
  8. Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD. Matza, L.S., Stoeckl, M.N., Shorr, J.M., Johnston, J.A. Expert. Rev. Pharmacoecon. Outcomes. Res (2006) [Pubmed]
  9. Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment. Matza, L.S., Buchanan, R., Purdon, S., Brewster-Jordan, J., Zhao, Y., Revicki, D.A. Schizophr. Bull (2006) [Pubmed]
  10. A review of the economic burden of ADHD. Matza, L.S., Paramore, C., Prasad, M. Cost. Eff. Resour. Alloc (2005) [Pubmed]
  11. Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review. Matza, L.S., Baker, T.M., Revicki, D.A. CNS. Drugs (2005) [Pubmed]
  12. Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. Matza, L.S., Secnik, K., Mannix, S., Sallee, F.R. Pharmacoeconomics (2005) [Pubmed]
  13. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. Matza, L.S., Rajagopalan, K.S., Thompson, C.L., de Lissovoy, G. J. Clin. Psychiatry (2005) [Pubmed]
WikiGenes - Universities